2؉ handling and excitationcontraction coupling. However, the cardiac effect of chronic CaMKII inhibition has not been well understood. Objective: We have tested the alterations of L-type calcium current (I Ca ) and cardiac function in CaMKII␦ knockout (KO) mouse left ventricle (LV). Methods and Results: We used the patch-clamp method to record I Ca in ventricular myocytes and found that in KO LV, basal I Ca was significantly increased without changing the transmural gradient of I Ca distribution. Substitution of Ba 2؉ for Ca 2؉ showed similar increase in I Ba . There was no change in the voltage dependence of I Ca activation and inactivation. I Ca recovery from inactivation, however, was significantly slowed. In KO LV, the Ca 2؉ -dependent I Ca facilitation (CDF) and I Ca response to isoproterenol (ISO) were significantly reduced. However, ISO response was reversed by ␤2-adrenergic receptor (AR) inhibition. Western blots showed a decrease in ␤1-AR and an increase in Ca v 1.2, ␤2-AR, and G␣i3 protein levels. Ca 2؉ transient and sarcomere shortening in KO myocytes were unchanged at 1-Hz but reduced at 3-Hz stimulation. Echocardiography in conscious mice revealed an increased basal contractility in KO mice. However, cardiac reserve to work load and ␤-adrenergic stimulation was reduced. Surprisingly, KO mice showed a reduced heart rate in response to work load or ␤-adrenergic stimulation. Conclusions: Our results implicate physiological CaMKII activity in maintaining normal I Ca , Ca 2؉ handling, excitationcontraction coupling, and the in vivo heart function in response to cardiac stress. (Circ Res. 2010;107:398-407.) Key Words: CaMKII Ⅲ calcium channel Ⅲ myocytes Ⅲ excitation-contraction coupling C aMKII is a multifunctional Ser/Thr protein kinase and a ubiquitously expressed multimer consisting of 8 to 12 subunits. This kinase has different isoforms in different tissues (␣, ␤, ␥, and ␦). In heart, the ␦ isoform is predominant, and the ␥ isoform is expressed at low levels. [1][2] [3] [4] CaMKII is an important regulator of several Ca 2ϩ handling proteins and ion channels; prominent among them is the L-type Ca 2ϩ channel (LTCC). 5, 6 LTCCs in myocytes are heteromultimers of at least 3 different subunits (␣1c, ␣2␦, and ␤2). The pore-forming ␣1c subunit (Ca v 1.2) specifies basic channel characteristics. The ␣2␦ and the auxiliary ␤ subunit are powerful modulators of channel expression, open probability, activation, and inactivation. 7, 8 I Ca is the key mediator for excitation-contraction (E-C) coupling. Excitation leads to opening of LTCCs, which allows the entry of a relatively small amount of Ca 2ϩ into the cell. The rise in intracellular Ca 2ϩ is then amplified by Ca 2ϩ -triggered Ca 2ϩ release from sarcoplasmic reticulum (SR) through ryanodine receptors. The increase in [Ca 2ϩ ] i from SR activates the myofilaments, leading to cell contraction.
C aMKII is a multifunctional Ser/Thr protein kinase and a ubiquitously expressed multimer consisting of 8 to 12 subunits. This kinase has different isoforms in different tissues (␣, ␤, ␥, and ␦). In heart, the ␦ isoform is predominant, and the ␥ isoform is expressed at low levels. [1] [2] [3] [4] CaMKII is an important regulator of several Ca 2ϩ handling proteins and ion channels; prominent among them is the L-type Ca 2ϩ channel (LTCC). 5, 6 LTCCs in myocytes are heteromultimers of at least 3 different subunits (␣1c, ␣2␦, and ␤2). The pore-forming ␣1c subunit (Ca v 1.2) specifies basic channel characteristics. The ␣2␦ and the auxiliary ␤ subunit are powerful modulators of channel expression, open probability, activation, and inactivation. 7, 8 I Ca is the key mediator for excitation-contraction (E-C) coupling. Excitation leads to opening of LTCCs, which allows the entry of a relatively small amount of Ca 2ϩ into the cell. The rise in intracellular Ca 2ϩ is then amplified by Ca 2ϩ -triggered Ca 2ϩ release from sarcoplasmic reticulum (SR) through ryanodine receptors. The increase in [Ca 2ϩ ] i from SR activates the myofilaments, leading to cell contraction.
LTCC in myocytes is regulated by multiple kinases, including protein kinase A (PKA), 9 protein kinase C (PKC), 10 CaMKII, 6 and calcineurin. 11 Among these regulatory pathways, PKA and CaMKII-dependent phosphorylation causes similar changes in I Ca , including the increase in the channel open probability and the duration of the open state. 12 In addition, a complex interplay between PKA and CaMKII has been revealed. 13 Recent studies have demonstrated that ␤ 1 -adrenergic receptor (AR) stimulation activates dual signaling pathways, cAMP/PKA and CaMKII, the former undergoing desensitization and the latter exhibiting sensitization with time. 13 This finding suggests that the CaMKII signaling pathway may be more important for long-term changes of Ca 2ϩ handling in the diseased heart, where increased sympathetic activation persists. 14 For instance, we found that in the pressure-overload heart failure mouse LV, I Ca was significantly altered with an increased density and slowed inactivation time course, and these changes are mainly caused by the increased CaMKII activity. 6 Although CaMKII activation has been linked to diseaserelated I Ca remodeling and reduced E-C coupling, the role of physiological CaMKII activity in the delicate regulation of I Ca , Ca 2ϩ handling, E-C coupling, and heart function has not been completely understood. In the present study, we tested the effects of long-term inhibition of basal CaMKII activity on the regulation of LTCC function, intracellular Ca 2ϩ transient, ventricular myocyte sarcomere shortening, and in vivo heart function by knocking out CaMKII␦, the predominant isoform in heart.
Methods

Isolation of Ventricular Myocytes
Mouse LV myocytes were isolated enzymatically by a protocol that we described previously. 6 
I Ca Recording
I Ca was recorded at room temperature using whole-cell patch-clamp methods described previously. 6 
Ca
2؉ Transient and Sarcomere Shortening Measurements
Ca 2ϩ transient and sarcomere shortening were recorded using IonOptix calcium imaging system (Milton, Mass) in myocytes loaded with fura-2/AM (Invitrogren).
Echocardiography
Echocardiography was performed in conscious mice using a murine echo machine, Visualsonics-RMV707B.
Statistical Analysis
Statistical analysis was performed using Sigmastat for Windows (Jandel Scientific). Paired and unpaired t tests and 1-way ANOVA analysis were used for comparisons, and PϽ0.05 was regarded as significant. Mann-Whitney rank sum tests were performed if tests for normality or equal variance failed.
Use of Vertebrate Animals
All experiments on live vertebrates were performed in accordance with protocols approved by the institution's animal care and use committee.
Statement of Responsibility
The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written. For detailed methods, please refer to the Online Data Supplements.
Results
CaMKII Knockout Mouse Model
In our genetic mouse model, CaMKII␦ has been knocked out, whereas the CaMKII␥ was unmodified. 15 These knockout (KO) mice are healthy and behave normally. The heart weight-tobody weight ratio (mg/g) for KO and wild-type (WT) mice was 4.83Ϯ0.1 (nϭ21) and 4.75Ϯ0.1 (nϭ23, PϾ0.05), respectively. The size of ventricular myocytes isolated from KO and WT mouse LV measured as cell capacitance was 159.10Ϯ3.34 pF (nϭ212 from 35 KO mice) and 154.24Ϯ3.01 pF (nϭ244 from 45 WT mice, PϾ0.05), respectively.
We measured total CaMKII activity in ventricular myocytes using a CaMKII activity assay kit (SignaTECT, Promega). 6 In preparations of myocytes from 2 WT and 2 CaMKII␦ KO mice, CaMKII activity was 2.18Ϯ0.47 pmol/ min/g for WT and 0.83Ϯ0.25 pmol/min/g for KO myocytes, Ϸ62% reduction in CaMKII␦ KO LV.
Increased L-Type Ca 2؉ Current Density in CaMKII␦ KO LV
We recently reported the transmural gradient of I Ca distribution in mouse heart LV. 6 To determine the transmural variation in I Ca density, we isolated myocytes from the subendocardial (SEN) and subepicardial (SEP) regions of CaMKII␦ KO mouse LV and recorded I Ca in these myocytes using the whole-cell voltage-clamp recording method. We found that I Ca density was significantly larger in SEP than in SEN myocytes (Figure 1 ). For instance, the peak I Ca (recorded at test potential of ϩ10 mV) was 7.9Ϯ0.4 pA/pF (nϭ25) for SEP and 6.5Ϯ0.3 pA/pF (nϭ21) for SEN myocytes (PϽ0.05). There was no difference in current decay kinetics or voltage dependence of I Ca activation between myocytes isolated from these 2 regions of the LV. The transmural gradient of I Ca density was similar to those recorded from WT LV, in which the peak I Ca was 6.8Ϯ0.3 pA/pF (nϭ28) for SEP and 5.5Ϯ0.1 pA/pF (nϭ26) for SEN myocytes (PϽ0.05). These results suggest that CaMKII inhibition has no effects on the spatial heterogeneity of I Ca distribution, consistent with our recently reported results 6 that CaMKII activity is similar between SEP and SEN myocytes. However, we found that I Ca density was significantly larger in KO LV than in WT LV. For instance, the peak I Ca in the SEP and SEN myocytes from KO LV was 15% and 18% larger than the I Ca recorded in these 2 regions of myocytes from WT LV, respectively (PϽ0.05). As shown in the I Ca -voltage relationship ( Figure 1C) , the voltage-dependence of I Ca activation was unchanged. This suggests that the increased I Ca probably is an increase in calcium channel conductance but not the shifting of voltage dependence of channel activation. To demonstrate this, we measured the channel conductance using the equation G c ϭI/(V m ϪV c ), where G c is the conductance, I is calcium current, V m is the membrane potential, and V c is the equilibrate potential. As predicted, calcium channel conductance was significantly larger in KO LV than in WT LV ( Figure 1D ). Normalizing channel conductance at each membrane potential to its maximum conductance for each individual myocyte revealed a V 1/2 and a slope factor of Ϫ11.83Ϯ0.63 mV and 3.71Ϯ0.20 mV for WT (nϭ50) versus Ϫ12.26Ϯ0.79 mV and 3.73Ϯ0.13 mV for KO myocytes (nϭ41), respectively (PϾ0.05) ( Figure 1E ).
Accelerated I Ca Inactivation in CaMKII␦ KO LV
To test the biophysical characteristics of I Ca in KO myocytes, we evaluated the kinetics of I Ca inactivation (current decay). Compared with the WT, I Ca inactivation was accelerated significantly and similarly in SEP and SEN myocytes isolated from KO LV. To quantify these changes, I Ca inactivation phase was fit by 2 exponential functions. 6 Mean values of the fast (1) and slow (2) time constants in WT (nϭ20) and KO myocytes (nϭ17) revealed robust differences ( Figure 1F ). I Ca inactivation was significantly accelerated at all testing potential levels in KO myocytes ( Figure 1 and Table 1 ). The accelerated I Ca inactivation is consistent with the reduced CaMKII-dependent LTCC phosphorylation.
Reduced I Ca Facilitation in CaMKII␦ KO LV
CaMKII activation is a major mediator for the Ca 2ϩ -dependent I Ca facilitation (CDF) in myocytes. 16, 17 We measured I Ca facilitation in CaMKII␦ KO ventricular myocytes. Consistent with the reduced CaMKII activity in KO myocytes, I Ca facilitation was observed in all recorded WT myocytes (nϭ77) but only in 76% of KO myocytes (nϭ46). In fact, instead of I Ca facilitation, a negative I Ca staircase was observed in 24% of KO myocytes ( Figure 1G ). Moreover, in those KO myocytes in which I Ca facilitation presents, the magnitude of I Ca facilitation was significantly smaller than that recorded in WT myocytes ( Figure 1H and Table 1 ). These results indicate that inhibition of physiological CaMKII activity in myocytes may significantly affect Ca 2ϩ influx at fast heart rates by reduction of CDF.
Molecular Mechanisms Underlying I Ca Alteration in CaMKII␦ KO Myocytes
It is known that CaMKII plays a stimulatory role in I Ca regulation. Acute inhibition of CaMKII reduces the ampli- tude of basal I Ca . 6 Interestingly, we observed a significantly increased I Ca density in ventricular myocytes from CaMKII␦ KO LV. Clearly, this cannot be explained by CaMKII inhibition. To test the molecular mechanisms for this observation, we measured protein levels of Ca v 1.2 and found that the Ca v 1.2 protein level was increased in KO myocytes by Ϸ12% compared with WT LV (Figure 2A and Figure 3E ). This percent increase in Ca v 1.2 protein level is consistent with the percent increase in I Ca density. Thus, it probably is the molecular basis for the increased I Ca in KO myocytes.
Recent studies have shown that CaMKII phosphorylates nuclear factor-kappaB (NFkB) component p65 and causes a nuclear translocation, leading to suppression of Ca v 1.2 channel expression. 18, 19 These findings revealed an inhibitory role of CaMKII in Ca v 1.2 channel expression. In KO ventricular myocytes, the decrease in CaMKII activity may remove this inhibition by preventing p65 nuclear translocation. Indeed, Western blot results demonstrated a significant reduction of nuclear p65 in KO ventricular myocytes ( Figure 2B and 2C). These results, then, well corroborate the increase in Ca v 1.2 expression observed in KO LV.
Voltage Dependence of I Ca Activation and Inactivation
To determine the voltage dependence of I Ca inactivation, we used a 2-pulse protocol (inset of Figure 2D , left) with a 2000-ms conditioning pulse at different potentials ranging from Ϫ80 mV to ϩ20mV (from a holding potential of Ϫ50 mV), followed by a 300-ms test pulse to ϩ10 mV. For the voltage dependence of I Ca activation, we used a holding potential of Ϫ50 mV and steps of 300-ms duration test pulses from Ϫ40 to ϩ70 mV in 10-mV steps (inset of Figure 2D , right). Using these approaches, we detected no significant voltage-dependent differences in I Ca activation and inactivation between myocytes from WT and KO LV ( Figure 2D ). Because there were no statistical differences in activation and inactivation kinetics of I Ca between SEP and SEN myocytes in either WT or KO LV, we analyzed these kinetics by not separating SEN and SEP myocytes. The half-maximal activation and inactivation voltages and slope factors in WT and KO LV are summarized in Table 1 .
Taken together, these data revealed that I Ca density is significantly increased in KO LV with increased Ca v 1.2 expression as the molecular basis, whereas the voltage dependence of I Ca activation and inactivation are not altered. 
Slowed I Ca Recovery From Inactivation in CaMKII␦ KO LV
To evaluate the kinetics of I Ca recovery from inactivation, we held cells at a holding potential of Ϫ50 mV and applied a 300-ms pulse to ϩ10 mV, followed by a variable time period (⌬T) at Ϫ50 mV and a 300-ms test pulse to ϩ10 mV ( Figure 2F , inset). The time course of I Ca recovery from inactivation was evaluated by fitting data for each cell with a mono-exponential equation. In both WT and KO LVs, we did not detect significant differences in I Ca recovery time constants between SEP and SEN myocytes. However, in KO LV, I Ca recovery from inactivation was significantly slowed ( Figure 2E and 2F and Table 1 ). The slowed I Ca recovery time course in KO ventricular myocytes (where CaMKII activity is chronically inhibited) is consistent with the results from acute CaMKII inhibition in ventricular myocytes 20 and SA node cells. 21 Reduced I Ca Response to ␤-Adrenergic Stimulation in CaMKII␦ KO LV ␤-Adrenergic stimulation is the major I Ca regulator in heart, which is mediated by both PKA and CaMKII Pathways. We tested I Ca response to ␤-adrenergic stimulation in CaMKII␦ KO ventricular myocytes. After basal I Ca was determined, myocytes were exposed to isoproterenol (ISO) at different concentrations (1 nmol/L, 10 nmol/L, 100 nmol/L, and 1 mol/L). When I Ca amplitude reached the steady state, myocytes were then exposed to the next ISO concentration. We found that I Ca response to ISO was significantly reduced in KO myocytes compared with WT ( Figure 3A and 3B) . As shown in the dose-response relationship ( Figure 3C ), the IC 50 was 12.15Ϯ1.19 nmol/L for WT and 15.70Ϯ3.05 nmol/L for KO myocytes (PϽ0.05). The maximum increase in I Ca by 1 mol/L ISO was 104.67Ϯ2.24% for WT and 74.28Ϯ3.25% for CaMKII␦ KO myocytes. The I Ca -voltage relationship showed that ISO (1 mol/L) shifted the peak I Ca potential from ϩ10 mV to 0 mV in both WT and KO myocytes, a 10-mV shift to the left ( Figure 3A and 3B) . These results suggest that inhibition of the physiological CaMKII activity significantly reduces ␤-adrenergic regulation on I Ca . The ISO-induced shifting of the I Ca -voltage relationship has been reported previously, and the underlying mechanisms involve the increased calcium channel availability and opening probability, although their quantitative importance varies from heart tissues. 22, 23 The shifting of the I Ca -voltage relationship suggests a membrane potential-dependent potentiating effect on I Ca .
To further explore the mechanisms for the increased I Ca density and reduced I Ca response to ␤-adrenergic stimulation in KO LV, we measured the protein levels of PKA-dependent phospholamban (PLB) phosphorylation at Ser16 (p-Ser16-PLB), total PLB, PKA, ␤-ARs, and the receptor-coupled GTP-binding protein (G s and G i ) protein levels in WT and KO LV. Our results revealed no change in protein levels of p-Ser16-PLB, PLB, PKA, and G s . However, a decrease in ␤1-AR and an increase in ␤2-AR and the inhibitory G protein G␣i3 levels were observed in KO LV. The ␤1-AR protein level was reduced by 37%, whereas the ␤2-AR and G␣i3 levels were increased by 58% and 64%, respectively ( Figure  3D and 3E) . The changes of ␤-ARs and G␣i3 can explain the reduced response of I Ca to ␤-adrenergic stimulation in KO myocytes. Unlike the AC3-I mouse model, in which CaMKII activity was totally inhibited and a significant increase in PKA activity was reported, 24 in our CaMKII␦ KO mouse model, levels of PKA expression and PKA-dependent PLB phosphorylation at Ser16 were unchanged ( Figure 3D and 3E ).
Barium Current Density in CaMKII␦ KO LV
We showed a significant increase in LTCC ␣-subunits Ca v 1.2 expression in CaMKII␦ KO LV, which is consistent with the increase in I Ca density seen in these myocytes. To further demonstrate that the increase in I Ca density is a result of increased channel expression but not Ca 2ϩ -related process, we substituted Ba 2ϩ for Ca 2ϩ in the I Ca recording solution and recorded barium current (I Ba ). Similar to I Ca , I Ba current density was significantly larger in both SEP and SEN myocytes in KO LV than in WT LV ( Figure 4A ). For instance, the peak I Ba was 6.84Ϯ0.55 pA/pF (nϭ15) for SEP and 5.24Ϯ0.42 pA/pF (nϭ15) for SEN myocytes in WT versus 8.95Ϯ0.66 pA/pF (nϭ16) for SEP and 6.61Ϯ0.28 pA/pF (nϭ17) for SEN myocytes in KO (PϽ0.05 for SEP versus SEN and WT versus KO). These results further point to the increased Ca v 1.2 expression as the molecular basis of increased I Ca in CaMKII␦ KO LV.
Reduced Response to ␤-Adrenergic Stimulation Was Reversed by Bypass or Blockade of ␤2-AR
We propose that the increase in ␤2-AR and G␣i3 expression levels is the molecular basis for the reduced I Ca response to ISO in KO myocytes. To further demonstrate this, we added 100 mol/L 8-Br-cAMP into a patch pipette solution to bypass the ␤-AR-mediation of the ISO response. 25 As predicted, in the presence of 8-bromo-cAMP, I Ca density was significantly larger in KO than in WT LV (Figure 4B) , indicating a reversal of ␤-adrenergic response in KO myocytes. The larger I Ca density in KO myocytes is consistent with the larger density of Ca v 1.2 expression. These results highly suggest that alterations of ␤2-AR and G␣i3 expression play an important role in the reduced I Ca response to ␤-adrenergic stimulation in KO myocytes. After bypass of the ␤2-AR-G␣i3 pathway, normal cAMP/ PKA regulation of I Ca was recovered.
To further confirm this, we tested ISO effects on I Ca in myocytes from WT and KO LV in the presence of the specific ␤2-AR antagonist ICI118,551 (10 nmol/L). 26 We found that the reduced ISO response in KO myocytes was reversed by the ␤2-AR antagonist ICI118,551 ( Figure 4C through 4E) . In the presence of ICI118,551 (10 nmol/L), ISO-induced potentiating effect on I Ca was reduced (from 101.61Ϯ4.64% to 68.83Ϯ6.97%, nϭ10, PϽ0.05) in WT myocytes but increased (from 72.32Ϯ8.42% to 95.83Ϯ8.91%, nϭ11, PϽ0.05) in KO myocytes. These results suggest that the net effect of ␤2-AR activation on I Ca in KO myocytes is inhibitory due to the increased inhibitory G protein G␣i3. In WT myocytes, however, ␤2-AR activation plays a predominantly stimulatory role in I Ca regulation.
To further elucidate the role of increased inhibitory G protein in reduced ISO response in KO ventricular myocytes, we used a G i inhibitor pertussis toxin 27, 28 (PTX) (myocytes were incubated at 37°C with 1.5 mg/mL PTX for at least 3 hours 27 ). PTX treatment significantly increased the ISO (1 mol/L) effect on I Ca in KO but not in WT myocytes. As a result, the ISO effect on I Ca became similar in KO and WT myocytes ( Figure 4F through 4H) . These results suggest that the inhibitory G proteins play an important role in I Ca regulation in KO myocytes but only a minor role in WT myocytes in response to ␤-adrenergic stimulation.
The ␤-AR expression is regulated at both transcriptional and posttranscriptional levels. Major transcriptional regulators of ␤-AR genes include glucocorticoid-responsive and thyroid hormone-responsive elements (GREs and TREs, respectively), with glucocorticoids downregulating ␤1-ARs and upregulating ␤2-ARs. 29 Thyroid hormone can upregulate ␤1-AR gene transcriptional activity, 30 whereas chronic exposure to ␤-AR-agonist results in downregulation of ␤1-AR protein and mRNA. 31 In the present study, we observed an increase in ␤2-AR/G i proteins in CaMKII␦ KO mice. However, whether these changes are specifically related to the reduction of CaMKII activity or adaptive is unknown. Figure  5 A and 5B) . The reduced Ca 2ϩ -transient at a fast pacing rate probably is associated with I Ca alterations, for example, accelerated current decay, slowed recovery from inactivation, and reduced I Ca facilitation, which lead to a reduction in Ca 2ϩ influx at fast stimulation. In addition, the reduction of basal CaMKII activity may also affect SERCA function, leading to reduced SR Ca 2ϩ contents at fast pacing. Indeed, we observed significant reduction of SR Ca 2ϩ content in KO myocytes at 1 and 3 Hz, with more prominent reduction at higher pacing rate, compared with WT myocytes ( Figure 5D ). This further contributes to the frequency-dependent reduction of Ca 
Altered
Altered In Vivo Heart Function in CaMKII␦ KO Mice
To test the in vivo cardiac effect of chronic CaMKII inhibition, we measured heart function in CaMKII␦ KO mice by echocardiography. Because anesthesia significantly affects cardiac function in mice, 34 echocardiography measurements were conducted in conscious mice using a high resolution murine echo machine (Visualsonics RMV707B with a 30-MHz transducer). Before collecting data for analysis, all mice were trained twice a day (morning and afternoon) by the operator with a 2-minute handling practice and echocardiography performance for 3 consecutive days. This practice performance largely reduced mouse stress during data acquisition. After 3 days training, heart function was then measured in the trained conscious mice.
Consistent with recent findings from a similar CaMKII␦ KO mouse model, 35 we found that KO mice have a basal (unstressed) heart rate similar to WT mice. However, KO mice showed an increased basal cardiac contractility with baseline LV fractional shortening (FS) of 55.77Ϯ0.74% for KO (nϭ38) versus 50.87Ϯ0.57% for WT mice (nϭ40, PϽ0.01). In line with this, Backs et al 15 also showed a tendency of increased FS in this CaMKII␦ KO mouse model although the increase did not reach significance. The increased basal I Ca in KO ventricular myocytes certainly play a role herein but a more complicated in vivo cardiac regulation or altered contractile machinery may exist and contribute. To test the response of CaMKII␦ KO mice to increased work load, we measured LV function before and after 15 minutes of swimming in warm water (Ϸ37°C). To enforce the mice to continuously swim, an appropriate weight was added to the mouse tail (a 2-g clamp).
We found that swimming significantly increased heart rate in WT mice. Surprisingly, heart rate was significantly reduced in KO mice by swimming (Table 2) .
Previous studies have demonstrated that CaMKII activity is required for the normal sinoatrial (SA) node function in rabbit heart, in which CaMKII inhibition by KN93 or AIP depressed the rate and amplitude of spontaneous action potentials (APs) in SA node cells in a dose-dependent manner (10 mol/L AIP or 3 mol/L KN-93 completely arrested SA node cells). 21 More recently, Wu et al 36 demonstrated that adrenergic regulation of heart rate is likely a result of CaMKIImediated regulation of SA nodal cell Ca 2ϩ homeostasis. CaMKII inhibition has no effect on the ISO response in SA nodal cells when SR Ca 2ϩ release is disabled. We showed that chronic inhibition of CaMKII activity in CaMKII␦ KO mice reduced Ca 2ϩ transient at fast pacing. This may explain why swimming failed to increase heart rate in KO mice. The alteration of Ca 2ϩ handling in CaMKII␦ KO mice limits the elevation of heart rate during work load. In addition to the reduced heart rate, swimming increased the LV fractional shortening (FS) by 31.37Ϯ3.48% in WT mice (nϭ9) but only 14.90Ϯ2.88% in KO mice (nϭ11, PϽ0.05). These results revealed a reduced cardiac reserve to excessive work load in CaMKII␦ KO mice. However, owing to the elevated basal contractility in CaMKII␦ KO mice, after swimming, the LV FS reached the same level in these 2 genotypes of mice.
To determine the effect of ␤-adrenergic activation on cardiac function, we tested the cardiac response to ISO injection at a dosage of 1.5 mg/kg IP. Similar to the results observed from swimming test, ISO (10 minutes after injection) increased LV contractility in CaMKII␦ KO mice less than in WT mice. The increase in FS was 23.43Ϯ1.90% for KO (nϭ30) versus 33.05Ϯ1.77% for WT (nϭ37, PϽ0.05), indicating a reduced sensitivity to ␤-adrenergic stimulation in KO mice. However, the absolute value of FS in the presence of ISO showed no difference between these 2 genotypes of mice (67.40Ϯ0.81% for WT versus 67.96Ϯ0.61% for KO mice) ( Table 2 ). Similar to the swimming test, ISO also induced a reduction of heart rate in KO mice. A representative short-axis 2-dimensional image-guided M-mode views of the LV echocardiography are shown in Figure 6 .
Discussion
I Ca is the trigger for SR Ca 2ϩ release and provides Ϸ25% of the Ca 2ϩ rise during systole. In addition, CaMKII-mediated I Ca facilitation contributes to the increased contractile force at faster heart rate, which improves cardiac performance during exercise. 37 There is growing evidence indicating a crucial role of CaMKII activation in the cardiac effects of acute and chronic ␤-adrenergic stimulation. Interestingly, our study demonstrated a resetting of I Ca in ventricular myocytes with genetic CaMKII inhibition. Instead of an anticipated decrease, I Ca density was significantly increased in CaMKII␦ KO LV. The increase in I Ca density is associated with the upregulation of LTCC Ca v 1.2. This increase in channel expression may compensate for the reduced CaMKII-dependent LTCC phosphorylation during the long-term CaMKII inhibition.
Several recent studies reported changes in I Ca in ventricular myocytes from mouse models with genetic CaMKII inhibition, for example, the mouse model with transgenic expression of a highly specific CaMKII inhibitory peptide (AC3-I) 24 and transgenic mice that express four concatenated repeats of the CaMKII inhibitory peptide AIP selectively in the SR membrane. 38 In these studies, 24, 38 I Ca facilitation has been totally abolished, supporting that CaMKII activation is the main molecular basis for CDF and implicating localized CaMKII activity in cardiac I Ca facilitation. Similar to our findings, Zhang et al 24 reported an increase in I Ca in AC3-I mouse LV and suggested that the increase in I Ca is associated with an increased PKA activity. However, neither total PKA protein expression nor local PKA activity (indicated by PKA-specific PLB phosphorylation at Ser16) has changed in our CaMKII␦ KO mice. In addition, we showed that saturation of PKA activation by internal application of 100 mol/L 8-bromo-cAMP did not change the difference in I Ca between WT and KO ventricular myocytes. These results ruled out the possibility that the I Ca difference between WT and KO ventricular myocytes is a result of the possible increase in bulk or local PKA activity in KO myocytes. Instead, our results indicate that the increase in I Ca density in CaMKII␦ KO mice is a result of increased Ca v 1.2 channel expression. In fact, in addition to the increased I Ca density, the I Ca decay was significantly accelerated in KO myocytes, which is consistent with the reduced channel phosphorylation (both PKA and CaMKII-dependent phosphorylation of LTCC slows I Ca decay). The inconsistency with the results from AC3-I mouse model is probably due to the different extent of CaMKII inhibition between these 2 genetic models. In the AC3-I mice, cardiac CaMKII activity was totally ablated. It is reasonable that the PKA pathway will take over the role of CaMKII in regulation of I Ca under the condition of CaMKII ablation. However, in our CaMKII␦ KO mouse LV, CaMKII activity is inhibited by Ϸ62% due to the unmodified CaMKII␥ isoforms. This largely but incompletely inhibited CaMKII activity probably mimics clinical therapeutic strategy. Thus, data from our CaMKII␦ KO mouse model are more clinically relevant.
Recent studies suggest that CaMKII may play a role in regulating Ca v 1.2 channel expression. This is based on the evidence that CaMKII phosphorylates NFkB component p65 and causes its nuclear translocation 39 and consequent suppression of Ca v 1.2 channel expression. 19 In our CaMKII␦ KO ventricular myocytes, p65 nuclear translocation is significantly reduced. As a result, NFkB-dependent inhibition of Ca v 1. contents and transients. As a result, steady-state twitch is reduced. 40 In our CaMKII␦ KO myocytes, the increased I Ca is probably a compensatory mechanism for triggering a larger SR Ca 2ϩ release to maintain an appropriate Ca 2ϩ transient and contractility in KO myocytes. However, consistent with the reduced CaMKII activity, I Ca facilitation was significantly reduced or abolished in CaMKII␦ KO myocytes. In a small portion of ventricular myocytes (Ϸ24%) from KO LV, a negative I Ca staircase was observed ( Figure 1G ). The reason for this is unclear. One possibility is that the proportional expression of CaMKII isoforms (␦ and ␥) in heart may vary from cell to cell and thus knockout of CaMKII␦ may reduce intracellular CaMKII activity more in some cells but less in others. Nevertheless, the reduced I Ca facilitation, in combination with the accelerated I Ca current decay and slowed recovery from inactivation, limits Ca 2ϩ influx at fast heart rate. As a result, the Ca 2ϩ -transient and sarcomere shortening were significantly reduced at fast pacing rate in CaMKII␦ KO myocytes ( Figure 5B and 5C) .
PKA is the primary regulator of I Ca in normal heart. It is known that both ␤1-AR and ␤2-AR couple to G s proteins to activate adenylate cyclase (AC), which mediates the conversion of adenosine triphosphate (ATP) into cAMP. This leads to the activation of PKA, which then phosphorylates several substrates, including LTCCs. Different from ␤1-AR, in addition to the G s proteins, ␤2-AR also couples to G i proteins, which counteract the G s coupled activation of AC, resulting in a reduction of cAMP level and thus producing an inhibitory effect. 41 In this study, we found that in CaMKII␦ KO LV, there was a reduction in ␤1-AR expression and a dramatic increase in ␤2-AR and the inhibitory G protein G␣i3 expression. These changes significantly decreased I Ca response to ␤-adrenergic activation.
Although echocardiography experiments performed in the conscious mice showed an increased basal LV contractility in CaMKII␦ KO mice, these mice have a reduced cardiac reserve to excessive work load and ␤-adrenergic activation. The reduced response to work load and ␤-adrenergic activation is consistent with the reduced ␤1-AR and the increase in ␤2-AR and G i protein expression. Although the FS was increased to a similar level between WT and KO mice in the presence of ISO or work load, the increase in cardiac output was significantly reduced in KO mice (compared with WT) due to the slowed heart rate under these stressed conditions, suggesting a reduction of cardiac response to stress.
Perspective
Recent studies highlighted the important roles of CaMKII in the regulation of Ca 2ϩ handling and E-C coupling. 42 In this study, I Ca channel upregulation in CaMKII␦ KO myocytes is likely an important mechanism to offset the expected decrease in Ca 2ϩ transient and contractility in response to chronic CaMKII inhibition. The increased ␤2-AR and G i protein expression and reduced heart rate in response to ␤-adrenergic activation and work load significantly reduced cardiac reserve to stress. These results implicate physiological CaMKII activity in heart in maintaining normal Ca 2ϩ transient, E-C coupling, and cardiac function in the basal and stressed conditions. However, as a limitation of this study, the role of physiological CaMKII activity in diseased conditions has not been investigated. In structural heart disease, for example, heart failure, the excessive adrenergic activity is needed to maintain pump function. Over time, this causes significant changes in adrenergic and CaMKII signaling with ␤-adrenergic signaling downregulated and CaMKII signaling enhanced. 13 Thus, a physiological CaMKII activity may be more important in the diseased heart.
